PHK
VRTX icon

Point72 Hong Kong’s Vertex Pharmaceuticals VRTX Stock Holding History

Point72 Hong Kong’s Portfolio VRTX Stock Details VRTX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q4 		– Sell
-9,800
Closed -$2.84M – 1651
2022
Q3 		$2.84M Buy
9,800
+4,900
+100% +$1.41M 0.1% 255
2022
Q2 		$1.38M Buy
+4,900
New +$1.31M 0.05% 440
2021
Q4 		– Sell
-5,600
Closed -$1.02M – 2433
2021
Q3 		$1.02M Sell
5,600
-25,800
-82% -$5.04M 0.03% 728
2021
Q2 		$6.33M Buy
31,400
+29,800
+1,863% +$6.23M 0.21% 77
2021
Q1 		$344K Sell
1,600
-500
-24% -$110K 0.01% 935
2020
Q4 		$496K Buy
+2,100
New +$482K 0.02% 700

Other funds holding VRTX

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
AllianceBernstein
AllianceBernstein Nashville, Tennessee $302B AUM 26.44% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Jennison Associates
Jennison Associates New York $167B AUM 44.17% 1-Year Est. Return

Point72 Hong Kong's VRTX Position: Q4 2022 in Review

Point72 Hong Kong sold out of Vertex Pharmaceuticals (VRTX) in Q4 2022, closing a stake of 16,683 shares — an estimated $4.83M sold.

Point72 Hong Kong first reported a position in VRTX in Q4 2014 and held it in 17 quarters. The position peaked at $4.83M in Q3 2022. 1,223 funds tracked by Wall St. Rank hold VRTX as of Q4 2022.

  • Point72 Hong Kong reported no remaining Vertex Pharmaceuticals position as of Q4 2022 after selling out during the quarter.
  • Point72 Hong Kong sold 16,683 Vertex Pharmaceuticals shares in Q4 2022, an estimated $4.83M.
  • Point72 Hong Kong first reported a position in Vertex Pharmaceuticals in Q4 2014 and held it in 17 quarters.
  • Point72 Hong Kong's Vertex Pharmaceuticals position peaked at $4.83M in Q3 2022.
  • 1,223 funds tracked by Wall St. Rank held Vertex Pharmaceuticals as of Q4 2022.

Based on Point72 Hong Kong's 13F filing for Q4 2022, filed 14 Feb 2023.